Which imaging modality is critical in staging thoracic cancer, evaluating the extent of metastatic disease, and in post-interventional surveillance?

Which imaging modality is critical in staging thoracic cancer, evaluating the extent of metastatic disease, and in post-interventional surveillance?

• A. CT
• B. MRI
• C. Ultrasound
• D. Sputum Culture

Answer: (A)

Imaging modality used for staging thoracic cancer, evaluating the extent of metastatic disease, and guiding post-intervention surveillance should give detailed anatomy of the chest and reliable detection of spread. CT provides fast, high-resolution cross-sectional images of the lungs, mediastinum, and chest wall, with the option of intravenous contrast to sharpen boundaries between tumor, vessels, and lymph nodes. This enables accurate measurement of the primary tumor, assessment of nodal involvement, and identification of distant metastases in common sites such as the liver, adrenals, bones, and lungs. Its wide availability and suitability for serial scans make it ideal for monitoring response after treatment and detecting recurrence over time. MRI offers excellent soft-tissue contrast but is less practical for routine whole-body staging and thoracic lung evaluation due to longer protocols and motion/artifact issues. Ultrasound has limited utility for imaging the lungs and mediastinum and is not a follow-up tool for thoracic metastatic surveillance. Sputum culture is a microbiologic test, not an imaging study. Thus, CT is the best fit for this role.

Imaging modality used for staging thoracic cancer, evaluating the extent of metastatic disease, and guiding post-intervention surveillance should give detailed anatomy of the chest and reliable detection of spread. CT provides fast, high-resolution cross-sectional images of the lungs, mediastinum, and chest wall, with the option of intravenous contrast to sharpen boundaries between tumor, vessels, and lymph nodes. This enables accurate measurement of the primary tumor, assessment of nodal involvement, and identification of distant metastases in common sites such as the liver, adrenals, bones, and lungs. Its wide availability and suitability for serial scans make it ideal for monitoring response after treatment and detecting recurrence over time. MRI offers excellent soft-tissue contrast but is less practical for routine whole-body staging and thoracic lung evaluation due to longer protocols and motion/artifact issues. Ultrasound has limited utility for imaging the lungs and mediastinum and is not a follow-up tool for thoracic metastatic surveillance. Sputum culture is a microbiologic test, not an imaging study. Thus, CT is the best fit for this role.